Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Daehan Nupharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	95,159	96,422	127,019	119,861	152,985	176,845
Market Cap Growth	-19.38%	-24.09%	5.97%	-21.65%	-13.49%	21.15%
Enterprise Value	152,582	114,707	125,867	131,114	172,368	194,665
Last Close Price	6780.00	6870.00	8921.08	8325.02	10506.75	12058.67
PE Ratio	9.30	6.23	10.13	4.93	9.75	-
PS Ratio	0.47	0.48	0.62	0.61	0.92	1.19
PB Ratio	0.75	0.77	1.16	1.16	1.86	2.99
P/TBV Ratio	0.76	0.78	1.17	1.17	1.87	3.00
P/FCF Ratio	-	-	44.89	11.08	25.68	43.32
P/OCF Ratio	14.72	5.09	10.11	8.41	9.23	13.06
EV/Sales Ratio	0.76	0.57	0.62	0.66	1.03	1.30
EV/EBITDA Ratio	8.04	5.04	5.63	4.21	5.80	7.41
EV/EBIT Ratio	10.31	6.15	6.67	4.69	6.53	8.38
EV/FCF Ratio	-3.76	-	44.48	12.12	28.93	47.69
Debt / Equity Ratio	0.64	0.47	0.34	0.36	0.45	0.66
Debt / EBITDA Ratio	4.21	2.61	1.64	1.18	1.24	1.49
Debt / FCF Ratio	-	-	12.93	3.39	6.20	9.60
Asset Turnover	0.93	1.01	1.18	1.21	1.15	1.15
Inventory Turnover	2.94	3.04	3.54	4.30	4.83	5.42
Quick Ratio	0.97	1.06	1.01	1.11	1.16	1.00
Current Ratio	1.61	1.61	1.60	1.75	1.69	1.34
Return on Equity (ROE)	8.24%	13.18%	11.81%	26.23%	22.15%	-16.82%
Return on Assets (ROA)	4.38%	5.86%	6.81%	10.68%	11.36%	11.15%
Return on Capital (ROIC)	5.07%	7.05%	8.25%	13.49%	15.14%	14.79%
Return on Capital Employed (ROCE)	8.90%	12.50%	16.40%	25.20%	23.40%	28.50%
Earnings Yield	10.76%	16.04%	9.87%	20.29%	10.26%	-5.72%
FCF Yield	-42.64%	-14.61%	2.23%	9.03%	3.90%	2.31%
Payout Ratio	13.71%	9.07%	11.19%	4.62%	-	-

Updated Nov 13, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.